Please use this identifier to cite or link to this item: http://earsiv.odu.edu.tr:8080/xmlui/handle/11489/4629
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSahin, Asena Keles-
dc.contributor.authorKukner, Ahmet Sahap-
dc.contributor.authorUlas, Fatih-
dc.contributor.authorDogan, Umit-
dc.date.accessioned2024-03-15T12:05:45Z-
dc.date.available2024-03-15T12:05:45Z-
dc.date.issued2020-
dc.identifier.citationSahin, AK., Kükner, AS., Ulas, F., Dogan, Ü. (2020). Effect of nepafenac 0.1% on retinal thickness after cataract surgery in patients without risk factors for cystoid macular edema. Int. J. Ophthalmol., 13(12), 1901-1907. https://doi.org/10.18240/ijo.2020.12.09en_US
dc.identifier.issn2222-3959-
dc.identifier.issn2227-4898-
dc.identifier.urihttp://dx.doi.org/10.18240/ijo.2020.12.09-
dc.identifier.urihttps://www.webofscience.com/wos/woscc/full-record/WOS:000596627600009-
dc.identifier.urihttp://earsiv.odu.edu.tr:8080/xmlui/handle/11489/4629-
dc.descriptionWoS Categories: Ophthalmologyen_US
dc.descriptionWeb of Science Index: Science Citation Index Expanded (SCI-EXPANDED)en_US
dc.descriptionResearch Areas: Ophthalmologyen_US
dc.description.abstractAIM: To evaluate the effect of topical preoperative nepafenac 0.1% treatment on postoperative macular edema using optical coherence tomography (OCT) after uncomplicated cataract surgery. METHODS: Ninety eyes of 90 patients without any risk factors were included in the study. The patients were assigned to three groups: group 1, treated with topical prednisolone acetate 1%; group 2, treated with topical nepafenac 0.1% in addition to prednisolone acetate (1%); and group 3, those who started receiving nepafenac 0.1% treatment 3d prior to surgery and continued the treatment postoperatively in addition to prednisolone acetate (1%). Central retinal thickness (CRT) and macular volume values were recorded using OCT at weeks 3 and 6. RESULTS: The increases in macular volume in the central 1 mm area after 3 and 6wk were significantly lower in patients who used prophylactic topical nepafenac preoperatively (group 3) compared with those in group 1 (P=0.028 and 0.008, respectively). No significant differences in the increase in macular volume and CRT were noted between groups 2 and 3 (P>0.05). In group 1, the increases in macular volume in the central 3 mm area at weeks 3 and 6 were significantly higher than that in group 2 and 3 (3rd week, P=0.004; 6th week, P=0.005). CONCLUSION: Nepafenac 0.1% treatment in addition to topical steroids after uncomplicated cataract surgery reduce the increase in macular volume in the early postoperative period.en_US
dc.language.isoengen_US
dc.publisherIJO PRESS-XI ANen_US
dc.relation.isversionof10.18240/ijo.2020.12.09en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectcataract surgery, cystoid macular edema, nepafenac, optic coherence tomography, retinal thicknessen_US
dc.subjectNONSTEROIDAL ANTIINFLAMMATORY DRUGS, KETOROLAC 0.4-PERCENT, VISUAL-ACUITY, DEXAMETHASONE, PREVENTION, INFLAMMATION, MANAGEMENT, BROMFENAC, EFFICACY, IMPACTen_US
dc.titleEffect of nepafenac 0.1% on retinal thickness after cataract surgery in patients without risk factors for cystoid macular edemaen_US
dc.typearticleen_US
dc.relation.journalINTERNATIONAL JOURNAL OF OPHTHALMOLOGYen_US
dc.contributor.departmentOrdu Üniversitesien_US
dc.contributor.authorID0000-0003-4468-3985en_US
dc.identifier.volume13en_US
dc.identifier.issue12en_US
dc.identifier.startpage1901en_US
dc.identifier.endpage1907en_US
Appears in Collections:Cerrahi Tıp Bilimleri

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.